Unicorn Capital Partners
China GPs re-up in ArriVent Biopharma's $155m Series B
Assorted Chinese investors have participated in a USD 155m Series B round for US-headquartered ArriVent Biopharma, which targets drug candidates emanating from emerging biotech hubs, including China.
China procurement services start-up raises $102m
Chinese procurement management platform Going-Link, also known as Zhenyun, has raised a RMB650 million ($102 million) Series C round led by Meituan-backed DragonBall Capital.
Boyu stands out in weak quarter for private equity fundraising
A quickfire fundraise by Boyu Capital – which saw $6 billion collected across two pools of capital in the space of a few months – accounted for more than one-quarter of all capital committed to Asia-focused private equity managers between April and June....
Fund focus: Unicorn does the hard yards
Six-year-old Unicorn Capital Partners has closed its latest China VC vehicle at the hard cap of $450 million, proving there is demand for fund-of-funds that offer something different
Unicorn raises $450m for VC fund-of-funds
China-focused venture capital fund-of-funds Unicorn Capital Partners has closed its latest vehicle at the hard cap of $450 million. The process took six months and the fund was oversubscribed
Glory raises $120m for second China venture fund
China's Glory Ventures has closed its second US dollar-denominated fund at $120 million, with VC-focused fund-of-funds Unicorn Capital Partners serving as the anchor LP.
Temasek leads round for China marketing content start-up
Tezign, a Chinese start-up that serves as a content-focused one-stop marketing solutions platform, has closed a second tranche of Series C funding that takes the overall total for the round to $100 million.
Asian fund-of-funds: Local linchpins
The Asian fund-of-funds community has shrunk considerably over the last 10 years as a result of M&A, withdrawals and repositioning. How do the survivors, from Axiom Asia and Asia Alternatives down, deliver value to LPs?
Virtual AGMs & IR: Up in the air
Private equity firms are still finding their feet with annual meetings that no longer take place on the ground. Like it or not, virtual engagement is set to become a larger part of investor relations from now on
Fund focus: Unicorn prepares for turbulence in China's VC space
China-focused venture capital fund-of-funds Unicorn Capital Partners, which has raised $350 million for its latest vehicle, expects consolidation in the tech investment space as underperforming GPs flounder
Fund focus: Unicorn sticks to early-stage remit
China venture capital-focused fund-of-funds Unicorn Capital Partners raises $250 million with an eye on an increasingly challenging but rewarding early-stage technology space
China biotech: Finding the formula
An eruption of investment and company creation in Chinese biotech has signaled the dawn of a raw but promising market. First-movers must negotiate immediate pitfalls while targeting long-term upside
Unicorn raises $250m for second China fund-of-funds
China-focused venture capital fund-of-funds Unicorn Capital Partners has closed its second fund at the hard cap of $250 million.
VC value-add: Personal touch
Chinese VC firms are expected to offer value-added services as a way of differentiating themselves from the competition. Are formalized concierge services for founders and their families a step too far?
Unicorn raises $210m for China VC fund-of-funds
Unicorn Capital Partners, a China-focused venture capital fund-of-funds launched by Emerald Hill Capital Partners alumnus Tommy Yip, has closed its debut fund at about $210 million.